This article traces the history of high-throughput screening (HTS), describes key technological milestones, and examines the ...
HTS automation integrates robotics, liquid handling, detection systems and software to streamline drug discovery workflows.
Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence imaging capabilities. It is best suited for high-content screening (HCS) and ...
The global High Throughput Screening Market was valued at USD 13370 Million in the year 2024 and is projected to reach a revised size of USD 17880 ...
High-throughput mass spectrometry (HT-MS) has emerged as an indispensable tool in drug discovery, offering rapid, sensitive and label‐free detection of biochemical transformations. By coupling ...
A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...
A biotech spin-out from the University of Cambridge has secured £2.9m to scale its cell assay technology and remove bottlenecks in cell screening.
Metanova Labs revolutionizes drug discovery by leveraging decentralized AI to screen billions of molecules efficiently.
Thought LeadersEdoardo FabiniPrincipal Scientist Evotec U.K. G-protein-coupled receptors (GPCRs) play a pivotal role in cellular signaling and have long been a major focus in drug discovery. These ...
New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...
Advancing neurological disorder research requires model systems that more accurately reflect the human brain. 3D cell cultures, such as organoids and spheroids, have emerged as game-changers by better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results